A statistical approach to central monitoring of data quality in clinical trials
暂无分享,去创建一个
Tomasz Burzykowski | Catherine Legrand | Marc Buyse | François Beckers | M. Buyse | C. Legrand | T. Burzykowski | Valerie Bee | D. Venet | E. Doffagne | F. Beckers | Yves Tellier | Eric Genevois-Marlin | Ursula Becker | V. Bée | V. Wilson | David Venet | Erik Doffagne | Yves Tellier | Eric Genevois-Marlin | Ursula Becker | Veronique Wilson
[1] Canary Wharf,et al. Reflection paper on risk based quality management in clinical trials , 2013 .
[2] Hans-Christoph Diener,et al. European Stroke Prevention Study 2. Efficacy and safety data. , 1997, Journal of the neurological sciences.
[3] M. Laakso,et al. The European Stroke Prevention Study , 1991, Neurology.
[4] Taghrid Obied,et al. Oversight of clinical investigations- A risk based approach to monitoring , 2014 .
[5] P. Lachenbruch,et al. The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials. , 1999, Statistics in medicine.
[6] Sheena McCormack,et al. The potential for central monitoring techniques to replace on-site monitoring: findings from an international multi-centre clinical trial , 2012, Clinical trials.
[7] T. Hill. A Statistical Derivation of the Significant-Digit Law , 1995 .
[8] Douglas G Altman,et al. Ensuring trial validity by data quality assurance and diversification of monitoring methods , 2008, Clinical trials.
[9] W. Härdle,et al. Applied Multivariate Statistical Analysis , 2003 .
[10] S. Lock,et al. Fraud and Misconduct in Biomedical Research , 2019 .
[11] James D Neaton,et al. Monitoring the quality of conduct of clinical trials: a survey of current practices , 2011, Clinical trials.
[12] Christian Ohmann,et al. Risk analysis and risk adapted on-site monitoring in noncommercial clinical trials , 2009, Clinical trials.
[13] M. Buyse,et al. Impact of on-site initiation visits on patient recruitment and data quality in a randomized trial of adjuvant chemotherapy for breast cancer , 2006, Clinical trials.
[14] I. Roberts,et al. Carbon cost of pragmatic randomised controlled trials: retrospective analysis of sample of trials , 2009, BMJ : British Medical Journal.
[15] David Moher,et al. The Good Clinical Practice guideline: a bronze standard for clinical research , 2005, The Lancet.
[16] Ich Harmonised,et al. INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE , 2006 .
[17] J. Abraham. The international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use , 2009 .
[18] Marc Buyse,et al. Fraud in Clinical Trials , 2005 .
[19] Peter Sandercock,et al. Sensible approaches for reducing clinical trial costs , 2008, Clinical trials.